opportunity

exhibit

Madrigal Pharmaceuticals Inc

data

$CACO Perhaps the biggest kick in the nuts is seeing this garbage $MDGL hit all time highs yesterday at $315 after reporting NASH data.

$MDGL as good as the phase 3 data was this is fuckin nuts and the manipulation couldn&#39;t be more blatant.

Data is not even as good as some competitors

$MDGL So many irregularities with the data.

$MDGL if you look at the data closer, it is actually a disgused failure.

This market is a shit show that wants to collapse and any bad data this will get eviscerated!

The data is dropping with an 830am eastern time conference call.

Leaving data to last possible minute isn’t a good sign.

market

$MDGL this stock market is so full of shit.

$MDGL $VKTX markets going up and this aint.

Suddenly you realize the market is not as big as they are claiming!

$MDGL This is a perfect example of what is wrong with this market still.

show

$MDGL Today is going to be an absolute shit show likely with markets tanking and no news here.

strike

suck

$MDGL For all the mean and rude assholes out there.

WTF Jerry even the neighborhood asshole can be civil.

$MDGL down down down let’s go bears fuck this piece of crap

$MDGL a lot of options for tomorrow are being fucked with.

Gave me opportunity to accumulate some more shares.

$MDGL nice opportunity to add a few hundred shares here 😆  the celebration of shorts today reminded me when the stock price dropped sharply by 27% in a couple of days before trial readout.

Potentially good opportunity IMO with $IONQ &amp; $MDGL.

Well for genius shorts who can&#39;t read medical data, this is a GREAT shorting opportunity.

But I agree this is a GREAT short opportunity.

$MDGL wow so strong 
 
great opportunity to admit you were wrong and cover your short

One of the biggest Biotech opportunities out there!

$MDGL buyout in the horizon for sure…
$GTHX is giving great opportunity right now.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

I don’t have to wait for fda approval for such low MC like ETNB is good promising data in next 3 weeks .. it can 3x my investments .. like AKRO is seating at 2B… ETNB HAS a strong potential for 2-3x from here next 3-4 weeks

This is an outstanding setup for $VKTX&#39;s VK2809 P2b study which is scheduled to release data in Q2 2023.

$VKTX from what I&#39;ve read from the preliminary trial data, the molecule is good, maybe better than $MDGL and has applications in weightloss.

$MDGL $ALT $TERN will wind up better with much better data.

With slam-dunk efficacy data and two years worth of safety data with no significant adverse safety events reported, Resmetirom has a clear path forward to accelerated approval.

$MDGL their PhIII data are so resoundingly positive that this has been termed a “watershed moment” and a “shock win” for the company.

bull

$MDGL cheers bulls great finish to the year!

$MDGL congrats to all longs and bulls here.

$MDGL benefits of owning low float market king bull.

$MDGL  
The MM now  
ok guys we did a great job this week let&#39;s celebrate Christmas and enjoy the fool&#39;s bulls&#39; money

$MDGL The horns on this bull are massive.

$MDGL - Congrats bulls on MDGL&#39;s stellar P3 performance and strong price run especially leading up to the holidays.

trial

$MDGL this is the cream of the crop, we already have stellar phase 3 results in the books.

Based on my multi year knowledge in NASH field, mdgl management so far did the best execution of clinical development - too many things to exemplify here!

Study results showed statistically significant absolute reductions in hepatic fat fraction at week 13 with pegozafermin administered every week or every two weeks compared to placebo.

After reaching its endpoints on its Phase 3 data we have seen a $240 spike!

Plus, remember this company is light years ahead of its competitors none of whom have had success with Phase 3. Bullish!

$VKTX Truth: VKTX increased more than 100% last 3 days since $MDGL has Phase 3 results.

DarioHealth Corp

manipulation

but manipulation and a little bit of profit taking on the daily.

I mean, this is a poster child for manipulation.

Manipulation - this stock price isnt real.

$DRIO Serious manipulation going on this morning.

quot

$DRIO A 3rd consecutive &quot;horrendous&quot; quarter put up by smoke and mirrors accounting.

And when you ask these &quot;bulls&quot; for DD - you know, to give them the benefit of the doubt - they scream personal insults.

but it&#39;s honestly kind of annoying when I keep seeing &quot;news any day&quot; for so many days in a row.

but the fact that I can&#39;t Google the company and this write up and have it generate a correct link, in addition to a lack of any &quot;about&quot; information in the write-up raises a big question mark for me.

joke

$DRIO C’mon Bulls…this is total bullshit here.

$DRIO still a complete joke for SP and market movement,

$DRIO Why does it always shows ridiculous price AH? Lol

profit

And paying a premium cutting into profits.

volume

Jan 26th it closed at $5.97
This is down $1.49 over 20 % in a month
But it’s low volume guys.

Gave me a great opportunity to explain what you all are doing.

Great investment opportunity for me at least.

$DRIO In my experience, when the overall market creates a follow-the-leader dip like this (vs. one generated by company news or factors), it is a great buying opportunity.

Asymmetric risk/reward opportunity drives 300%+ potential upside.

We now see double-digit non-GAAP EPS growth each period [quarterly, annual] into FY23, as seen in Exhibit 2.

growth

$DRIO even in this crap market this should be 10$ half the multiple of similar comps with twice the growth!

The growth of the B2B business has resulted in an overall significant improvement in the financial profile of the Company.

They have reached operating leverage and continued growth will make this company soon profitable.

I&#39;m excited for Matt to join at this juncture in our growth, as we recently signed our 100th contract and the market demand for integrated solutions continues to grow.

Looking at the last year, $DRIO shows a very strong growth in Revenue.

Looking forward to another year of outstanding revenue growth, margin inflection, &amp; new major partners.

Premier growth profile, inflecting margins &amp; profitability, small float, dirt cheap valuation.

$DRIO I’ve never seen anything like this…Best-in-Class revenue growth by miles for 1/10th of the valuation cost; major strategic partners $CVS &amp; $SNY; plenty of cash.

revenue

Its a big freaking revenue funnel to start!! !

- 100 contracts reached 
- obviously bullish JPM conference 
- pre-announced revenue beat and likely EPS beat
- DXCM partnership 

This all happened in 5 weeks.

We believe that the expected 2022 results are especially exciting because B2B revenue represents the majority of our revenue for the first time.

$DRIO $AMWL $TDOC - drio continues to execute in the digital health space - growing revenues and reducing burns - signing bigger and bigger names : no brainer if u love the space

First-time revenue guide for 2023 could also catapult this to new highs.

Look at my sweetheart stock FLNT -- on pace for 400M in annual revenue and PROFITABLE!

Volume yesterday suggests bulls are in it to win it.

$DRIO  
 
Bulls - notice an increase in the number of people last 12 hours telling you this stock is a good one

Gladstone Commercial Corp

$GOOD I remember unloading all my shares on 1/11 at $17 when they cut the dividend, and somebody was telling me how they did the opposite and it was such a buying opportunity.

$GOOD just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/good/0001193125-23-074452.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=good

$GOOD just filed with the SEC a New Agreement and a Financial Exhibit https://last10k.com/sec-filings/good/0001193125-23-005580.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=good

$GOOD just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/good/0001193125-22-302740.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=good

$GOOD just filed with the SEC a Earnings Release and a Financial Exhibit https://last10k.com/sec-filings/good/0001234006-22-000016.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=good

rating

$GOOD latest rating from EF Hutton and Company on 2023-02-24, setting target price at: USD 18.00 with a rating of Buy.

$GOOD NEW ARTICLE : Colliers Securities Sticks to Their Buy Rating for Gladstone Commercial (GOOD) https://www.stck.pro/news/GOOD/37286749

$GOOD NEW ARTICLE : EF Hutton Sticks to Their Buy Rating for Gladstone Commercial (GOOD) https://www.stck.pro/news/GOOD/37269370

announces

Gladstone Commercial Corporation Announces Common Stock Repurchase Authorization MCLEAN, Va.,  https://www.conferencecalltranscripts.org/summary/?id=11925505 $GOOD

$GOOD 📰 Gladstone Commercial Corporation Announces Common Stock Repurchase Authorization

https://quantisnow.com/i/4222623?utm_source=stocktwits

45 seconds delayed.

Gladstone Commercial Corporation Announces Share Repurchase Authorization MCLEAN, Va.,  https://www.conferencecalltranscripts.org/summary/?id=11606287 $GOOD

$GOOD 📰 Gladstone Commercial Corporation Announces Share Repurchase Authorization

https://quantisnow.com/i/3793044?utm_source=stocktwits

45 seconds delayed.

company

$GOOD GOOD / Gladstone Commercial Corporation Price Target Updated 
https://fintel.io/sfo/us/good

$GOOD 📜 SEC Form S-3ASR filed by Gladstone Commercial Corporation Real Estate Investment Trust

https://quantisnow.com/i/3728004?utm_source=stocktwits

45 seconds delayed.

Gladstone Commercial Corporation director just declared owning 350 shares of Gladstone Commerci https://www.conferencecalltranscripts.org/summary/?id=11401896 $GOOD

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Mar, 9, 2023

Feb, 24, 2023

DRIO

DarioHealth Corp

-25.48%

$5.77 - $4.30

Dec, 12, 2022

Dec, 2, 2022

GOOD

Gladstone Commercial Corp

-28.20%

$16.70 - $11.99

Mar, 16, 2023

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Mar, 9, 2023

Feb, 24, 2023

Jan, 20, 2023

Jan, 6, 2023

Dec, 30, 2022

Dec, 30, 2022

Dec, 29, 2022

Dec, 28, 2022

Dec, 23, 2022

DRIO

DarioHealth Corp

-25.48%

$5.77 - $4.30

Dec, 12, 2022

Dec, 2, 2022

Dec, 1, 2022

Oct, 13, 2022

Sep, 30, 2022

GOOD

Gladstone Commercial Corp

-28.20%

$16.70 - $11.99